[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-563887-105":59,"doc-detail-563887-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","establishment-of-a-new-classification-system-for-chronic-inflammatory-demyelinating-polyneuropathy-based-on-unsupervised-machine-learning","Establishment of a new classification system for chronic inflammatory demyelinating polyneuropathy based on unsupervised machine learning","","A clinical prediction model for immunotherapy responsiveness in chronic inflammatory demyelinating polyneuropathy (CIDP) is not well established. This study aimed to create a new CIDP classifier using clinical characteristics, laboratory findings, and electrophysiological features. Data from 172 treatment-naïve CIDP patients (2003–2019) were analyzed via unsupervised hierarchical clustering, followed by tree-based models. Results identified three clusters with distinct severity and treatment response patterns and a high-accuracy four-feature classifier.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/establishment-of-a-new-classification-system-for-chronic-inflammatory-demyelinating-polyneuropathy-based-on-unsupervised-machine-learning/563887/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/establishment-of-a-new-classification-system-for-chronic-inflammatory-demyelinating-polyneuropathy-based-on-unsupervised-machine-learning/563887.png","ImageObject",300,407,{"name":92,"@type":93},"Olivia Brown","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-16","2026-10-12",true,{"@type":102,"interactionType":103,"userInteractionCount":29},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What is the primary goal of this study on CIDP classification?","Question",{"text":112,"@type":113},"To establish a new classification system for CIDP patients that predicts responsiveness to immunotherapy using clinical, laboratory, and electrophysiological features.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How were CIDP patient subgroups identified in the study?",{"text":117,"@type":113},"Clinical, laboratory, and electrophysiological features from 172 treatment-naïve patients were analyzed using unsupervised hierarchical clustering to discover patient clusters.",{"name":119,"@type":110,"acceptedAnswer":120},"What key differences were observed across the three identified clusters?",{"text":121,"@type":113},"The clusters differed in disability assessment scores, fulfillment of demyelinating criteria, and comorbid features such as chronic kidney disease and hypoalbuminemia, with different responsiveness rates to pulse steroid therapy.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},563887,1792287677,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":29,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":44,"language":139,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":140,"faqs":141,"seo_title":142,"seo_description":67,"update_tm":143,"read_time":144,"preview_page_count":19,"preview_urls":145},16904993612988,"https://ap-avatar.wpscdn.com/davatar_a8503ba1806abce46bf441b54a3ca4cd","Received: 22 December 2021 Revised: 2 August 2022 Accepted: 7 August 2022  \nDOI: 10.1002/mus.27702  \nCL INI CA L RE SEAR CH A RTI CLE  \nEstablishment of a new classification system for chronic inflammatory demyelinating polyneuropathy based on unsupervised machine learning  \nChun-Wei Chang MD1  | Long-Sun Ro MD, PhD1,2 | Rong-Kuo Lyu MD1,2 | Hung-Chou Kuo MD1,2  | Ming-Feng Liao MD1,2 | Yih-Ru Wu MD1,2 | Chiung-Mei Chen MD, PhD1,2 | Hong-Shiu Chang MD, PhD1,2 |  \nYi-Ching Weng MD3  | Chin-Chang Huang MD1,2 | Kuo-Hsuan Chang MD, PhD1,2   \n1Department of Neurology, Linkou Chang Gung Memorial Hospital, Taoyuan, Taiwan 2Collage of Medicine, Chang Gung University, Taoyuan, Taiwan  \n3Department of Neurology, New Taipei Municipal Tucheng Hospital, New Taipei City, Taiwan  \nCorrespondence  \nKuo-Hsuan Chang, Department of Neurology, Chang Gung Memorial Hospital-Linkou Medical Center, No.5, Fusing St., Gueishan Dist., Taoyuan City 333, Taiwan.  \nEmail: [gophy5128@adm.cgmh.org.tw](gophy5128@adm.cgmh.org.tw); [gophy5128@cgmh.org.tw](gophy5128@cgmh.org.tw)  \nLong-Sun Ro, Department of Neurology, Chang Gung Memorial Hospital-Linkou Medical Center, No.5, Fusing St., Gueishan Dist., Taoyuan City 333, Taiwan.  \nEmail: [cgrols@adm.cgmh.org.tw](cgrols@adm.cgmh.org.tw); [cgrols@cgmh.org.tw](cgrols@cgmh.org.tw)  \nFunding information  \nChang Gung Memorial Hospital, Grant/Award Numbers: CMRPG3C1631, CMRPG3H0101  \nAbstract  \nIntroduction/Aims: A model for predicting responsiveness to immunotherapy inpatients with chronic inflammatory demyelinating polyneuropathy (CIDP) has not been well established. We aimed to establish a new classifier for CIDP patients based on clinical characteristics, laboratory findings, and electrophysiological features.  \nMethods: The clinical, laboratory, and electrophysiological features of 172 treatment-naïve patients with CIDP between 2003 and 2019 were analyzed using an unsupervised hierarchical clustering. The identified pivotal features were used to establish simple classifications using a tree-based model.  \nResults: Three clusters were identified: 1, n = 65; 2, n = 70; and 3, n = 37. Patients in Cluster 1 scored lower on the disability assessment score before treatment. More patients in Clusters 2 (90 . 0%) fulfilled demyelinating criteria than patients in Cluster 1 (30 . 8%, p \u003C . 001) . Cluster 3 had more patients with chronic kidney disease (CKD) (27.0%) and hypoalbuminemia (3.40 g/dL) than did Cluster 2 (CKD: 0%, p \u003C . 001; hypoalbuminemia: 4 . 09 g/dL, p \u003C . 001) . The responsiveness to pulse steroid therapy was higher in Cluster 2 (70.0%) than in Clusters 1 (31 . 8%; p = . 043) and 3 (25 . 0%; p = . 014) . A tree-based model with four pivotal features classified patients in our cohort into new clusters with high accuracy (89 . 5%) .  \nDiscussion: The established hierarchical clustering with the tree-based model identified key features contributing to differences in disease severity and response to pulse steroid therapy. This classification system could assist clinicians in the selection of treatments and could also help researchers by clustering patients for clinical treatment trials.  \nAbbreviations: CIDP, chronic inflammatory demyelinating polyneuropathy; CKD, chronic kidney disease; CMAP, compound muscle action potentials; CV, conduction velocity; DADS, distal acquired demyelinating symmetric polyneuropathy; DL, distal latency; EFNS/PNS, European Federation of Neurological Societies/Peripheral Nerve Society; FAMD, factor analysis of mixed data; INCAT, Inflammatory Neuropathy Cause and Treatment; IQR, interquartile range; IVIg, intravenous immunoglobulin; MADSAM, multifocal acquired demyelinating sensory and motor neuropathy.  \nMuscle & Nerve. 2022;66:603–611.  \n[wileyonlinelibrary.com/journal/mus](wileyonlinelibrary.com/journal/mus)  \n© 2022 Wiley Periodicals LLC.  \n603  \n10974598, 2022, 5, Downloaded from [https://onlinelibrary.wiley.com/doi/10.1002/mus.27702 by Egyptian National Sti. Network (Enstinet), Wi","cbCaigXM67wVibHX","https://ap.wps.com/l/cbCaigXM67wVibHX","pdf",1385754,"English","# Abstract\n## Introduction/Aims\n## Methods\n## Results\n## Discussion\n# Abbreviations\n# Introduction","[{\"question\":\"What is the primary goal of this study on CIDP classification?\",\"answer\":\"To establish a new classification system for CIDP patients that predicts responsiveness to immunotherapy using clinical, laboratory, and electrophysiological features.\"},{\"question\":\"How were CIDP patient subgroups identified in the study?\",\"answer\":\"Clinical, laboratory, and electrophysiological features from 172 treatment-naïve patients were analyzed using unsupervised hierarchical clustering to discover patient clusters.\"},{\"question\":\"What key differences were observed across the three identified clusters?\",\"answer\":\"The clusters differed in disability assessment scores, fulfillment of demyelinating criteria, and comorbid features such as chronic kidney disease and hypoalbuminemia, with different responsiveness rates to pulse steroid therapy.\"}]","Establishment of a new classification system for chronic inflammatory demyelinating polyneuropathy based on unsupervised machine learning | PDF",1791839160,23,[146,150,154,158],{"page_no":8,"url":147,"width":148,"height":149},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-17/3fac2a2f97ec41f1b649aa314f723fc3.webp",983,1291,{"page_no":14,"url":151,"width":152,"height":153},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-17/9e1d3817b1f931bc7c8d8a9027e3664b.webp",982,1290,{"page_no":81,"url":155,"width":156,"height":157},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-17/429bb1720613117e9f0cd8c5eef1c6b2.webp",981,1289,{"page_no":19,"url":159,"width":160,"height":161},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-17/8d8bf04182bb727d1cb8fe16b6c741b1.webp",980,1287]